Vernalis plc and Tris Pharma, Inc. ("Tris") are pleased to announce that the U.S. Food and Drug Administration ("FDA") has confirmed that the New Drug Application ("NDA") for Tuzistra™ XR ("CCP-01") has been accepted for full review. This triggers a milestone payment from Vernalis to Tris.
Research
Obama's BRAIN initiative awards $46 million in grants
Wearable brain scanners and lasers that can turn hundreds of cells on and off were among 58 projects awarded $46 million in federal grants as part of President Obama's $100 million initiative to unlock the secrets of the human brain.
New York scientists unveil 'invisibility cloak' to rival Harry Potter's
Watch out Harry Potter, you are not the only wizard with an invisibility cloak. Scientists at the University of Rochester have discovered a way to hide large objects from sight using inexpensive and readily available lenses a technology that seems to have sprung from the pages of J.K. Rowling's Harry Potter fantasy series.
India reaches Red Planet, but at home red tape binds space firms
As India celebrated becoming the first Asian nation to reach Mars, S.M. Vaidya, head of business at conglomerate Godrej's aerospace division that made the spacecraft's engine and thruster components, sounded surprisingly downbeat.
India triumphs in maiden Mars mission, sets record in space race
India's low-cost mission to Mars successfully entered the red planet's orbit on Wednesday, crowning what Prime Minister Narendra Modi said was a "near impossible" push to become the only country to complete the trip on its maiden attempt.
Latest News
Microsoft Corp co-founder Paul Allen's charitable foundation on Thursday will announce it is donating $9 million to support U.S. efforts to fight the Ebola outbreak in West Africa, a source familiar with the matter said.
Harvard University has received the largest donation in its history, the school announced on Monday: $350 million from the Morningside Foundation to the School of Public Health.
Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.
A group of companies, including several large automakers, have joined a public-private research initiative to lay the groundwork for a system that wirelessly connects vehicles and helps smooth the flow of traffic, the University on Michigan said on Friday.
Oregon researchers developing a vaccine that has shown promise in preventing HIV infection in primates said on Wednesday they have been awarded a $25 million grant from the Bill & Melinda Gates Foundation.
Google Inc said a research team led by physicist John Martinis from the University of California Santa Barbara will join the company to start a project to build new quantum information processors based on superconducting electronics.
International Business Machines Corp on Wednesday launched a computer system that can quickly identify patterns in massive amounts of data, an ability that IBM said should hasten breakthroughs in science and medical research.
The US National Institutes of Health has awarded Oraya Therapeutics with a $215,000 Small Business Technology Transfer Grant to investigate gold nanoparticles development.
Seattle-based Juno Therapeutics announced it has closed Series B round of funding with $134 million. The new funding came from previous investors including ARCH Venture Partners, Alaska Permanent Fund, Bezos Expedition, the personal investment company of Amazon founder Jeff Bezos, and Venrock. Also participating in Series B are 10 other mutual funds and healthcare-related funds that wish to remain anonymous.
